Filing metadata

Accession number
0001493152-22-036643
Form type
Form 4
Filer
BriaCell Therapeutics Corp.
CIK
CIK 1610820
Filed
Dec 28, 2022
Reporting period
Dec 23, 2022
Description
Insider transaction

Explore SEC Filings Hub